MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
Dechen Fu(Cleveland Clinic Lerner College of Medicine), Brian Gastman(Cleveland Clinic)
Cited by 24
Related Papers
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
|Nature Medicine|2023|208
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
|BMC Cancer|2018|142
Guidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression Profiling
|Future Oncology|2019|84
Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
|SKIN The Journal of Cutaneous Medicine|2023|25